Gene editing company CRISPR Therapeutics (CRSP) made a basing pattern in the January-July time frame and the indicators support the potential for further price gains. Let's check out the charts.
More from Investing
Like or not, this is classic bear market action playing out.
The charts don't look very appetizing for the spice company.
The charts show further declines ahead for the credit card company.
When one of the last holdouts of the S&P 500 turns down the selloff is in full gear.